Global Drug Facility

On Monday July 6, Johnson & Johnson announced a price reduction of the anti-tuberculosis medicine bedaquiline, for low- and middle-income countries. Thanks to the support of USAID and the Global Fund, this price reduction could be achieved. The price dropped from $400 to $340 for a six-month treatment regimen.

While coronavirus (COVID-19) dominates the news, we need to remember that another respiratory disease kills 1.5 million people per year: tuberculosis (TB). This is an opportunity to unite forces in the fight against TB and coronavirus.

As procurement agent for Stop TB /GDF, we are glad to share this news update as announced by the Stop TB partnership during the 50th Union Conference for Lung Health in Hyderabad, India.

Each year we recognise World TB Day on March 24 to raise public awareness about the devastating health, social and economic impact of TB and urge acceleration of efforts to end the global TB epidemic.